EyePoint, Inc.

EYPT

As of the close on Sep 25, 2026

Price

$3.62

Market cap

—

The cover-page share count does not match the latest report's share count

P/E (diluted TTM)

—

A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given

EPS (TTM)

—

A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given

Dividend yield

—

Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How EyePoint, Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: EyePoint, Inc. — 10-Q filed Aug 5, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 27, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among EyePoint, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

2026-01-05 · Ribeiro Ramiro: Larger than 15 of the 16 other insider sales of Common Stock on file. SEC filing
2025-12-04 · Cormorant Asset Management, LP: Larger than all 16 other insider sales of Common Stock on file. SEC filing
2024-05-06 · Cormorant Asset Management, LP: Larger than all 12 other insider purchases of Common Stock on file. SEC filing
2024-04-18 · Cormorant Asset Management, LP: Larger than 11 of the 12 other insider purchases of Common Stock on file. SEC filing

Independent insiders buying near the same time

2024-08-16–2024-08-21: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2026-04-17	Ribeiro Ramiro · Chief Medical Officer	Common Stock	S — Open market or private sale	−2,437	15.00	SEC filing
2026-03-16	Duker Jay S. · President and CEO	Common Stock	P — Open market or private purchase	+1,500	13.15	SEC filing
2026-03-04	Ribeiro Ramiro · Chief Medical Officer	Common Stock	S — Open market or private sale	−2,438	17.87	SEC filing
2026-02-17	Ribeiro Ramiro · Chief Medical Officer	Common Stock	S — Open market or private sale	−2,437	15.00	SEC filing
2026-01-05	Ribeiro Ramiro · Chief Medical Officer	Common Stock	S — Open market or private sale	−42,544	17.10	SEC filing
2025-12-04	Cormorant Asset Management, LP · Other	Common Stock	S — Open market or private sale	−60,000	15.70	SEC filing
2025-12-04	Lurker Nancy · Director	Common Stock	S — Open market or private sale	−9,300	15.11	SEC filing
2025-11-28	Lurker Nancy · Director	Common Stock	S — Open market or private sale	−500	14.95	SEC filing

Showing 8 of 20 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-05-25	Elston George · Chief Financial Officer	Common Stock	M — Exercise or conversion of derivative security	+7,500	SEC filing
2026-05-25	Elston George · Chief Financial Officer	Restricted Stock Units	M — Exercise or conversion of derivative security	−7,500	SEC filing
2026-05-25	Elston George · Chief Financial Officer	Common Stock	F — Payment of exercise price or tax by delivering securities	−3,627	SEC filing
2026-04-17	Ribeiro Ramiro · Chief Medical Officer	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−2,437	SEC filing
2026-04-17	Ribeiro Ramiro · Chief Medical Officer	Common Stock	M — Exercise or conversion of derivative security	+2,437	SEC filing
2026-03-04	Ribeiro Ramiro · Chief Medical Officer	Common Stock	M — Exercise or conversion of derivative security	+2,438	SEC filing
2026-03-04	Ribeiro Ramiro · Chief Medical Officer	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−2,438	SEC filing
2026-03-02	Elston George · Chief Financial Officer	Common Stock	G — Bona fide gift	−5,000	SEC filing

Showing 8 of 40 rows

Other activity

		Security	Code		Filing
2026-03-23	Duker Jay S. · President and CEO	Common Stock	J — Other acquisition or disposition	−76,766	SEC filing
2026-03-23	Duker Jay S. · President and CEO	Stock Option (Right to Buy)	J — Other acquisition or disposition	+52,500	SEC filing
2026-03-23	Duker Jay S. · President and CEO	Stock Option (Right to Buy)	J — Other acquisition or disposition	+97,500	SEC filing
2026-03-23	Duker Jay S. · President and CEO	Stock Option (Right to Buy)	J — Other acquisition or disposition	−97,500	SEC filing
2026-03-23	Duker Jay S. · President and CEO	Common Stock	J — Other acquisition or disposition	+76,766	SEC filing
2026-03-23	Duker Jay S. · President and CEO	Stock Option (Right to Buy)	J — Other acquisition or disposition	−52,500	SEC filing
2025-06-23	Duker Jay S. · President and CEO	Common Stock	J — Other acquisition or disposition	−56,665	SEC filing
2025-03-19	Duker Jay S. · President and CEO	Common Stock	J — Other acquisition or disposition	−20,000	SEC filing

Showing 8 of 8 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.